A New Variable Influencing HCV-Related Liver Disease in HIV-HCV Coinfected Individuals?

Gastroenterology

Volumn 133, Issue 6, 2007, Pages 2042-2045

  Stapleton, Jack ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10;

ADAPTIVE IMMUNITY; DISEASE COURSE; EDITORIAL; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS GB VIRUS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER FIBROSIS; LIVER INJURY; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE; VIREMIA; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 36549029881     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.10.032     Document Type: Editorial

References (28)

1. Bica I., McGovern B., Dhar R., et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32 (2001) 492-497
2. Sulkowski M.S., and Thomas D.L. Hepatitis C in the HIV-infected person. Ann Intern Med 138 (2003) 197-207
3. Pineda J.A., Garcia-Garcia J.A., Aguilar-Guisado M., et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 46 (2007) 622-630
4. Liang T.J., Rehermann B., Seeff L.B., et al. Pathogenesis, natural history, treatment and prevention of hepatitis C. Ann Intern Med 132 (2000) 296-305
5. Dustin L.B., and Rice C.M. Flying under the radar: the immunobiology of hepatitic C. Annu Rev Immunol 25 (2007) 71-99
6. Stapleton J.T. GB virus type C/hepatitis G virus. Semin Liver Dis 23 (2003) 137-148
7. Rey D., Vidinic-Moularde J., Meyer P., et al. High prevalence of GB virus C/hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 19 (2000) 721-724
8. Alter H.J. G-pers creepers, where'd you get those papers?. A reassessment of the literature on the hepatitis G virus. Transfusion 37 (1997) 569-572
9. Pessoa M.G., Terrault N.A., Detmer J., et al. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 27 (1998) 877-880
10. Fogeda M., Navas S., Martin J., et al. In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol 73 (1999) 4052-4061
11. Xiang J., Wunschmann S., Schmidt W.N., et al. Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-Positive T cells. J Virol 74 (2000) 9125-9133
12. George S.L., Varmaz D., and Stapleton J.T. GB virus C replicates in primary T and B lymphocytes. J Infect Dis 193 (2006) 451-454
13. Zhang W., Chaloner K., Tillmann H.L., et al. Effect of early and late GBV-C viremia on survival of HIV infected individuals: A meta-analysis. HIV Med 7 (2006) 173-180
14. Bjorkman P., Flamholc L., Naucler A., et al. GB Virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 18 (2004) 877-886
15. Williams C.F., Klinzman D., Yamashita T.E., et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350 (2004) 981-990
16. Van der Bij A.K., Kloosterboer N., Prins M., et al. GB Virus C coinfection and HIV-1 disease progression: The Amsterdam cohort study. J Infect Dis 191 (2005) 678-685
17. Berzsenyi M.D., Bowden D.S., Kelly H.A., et al. Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection. Gastroenterology 133 (2007) 1821-1830
18. Flynn J., Dore G., Hellard M., et al., Australian Trial in Acute HCV Study Group. Early predominant IL-10 production without IFN-g in individuals with acute HCV that progress to chronic infection. 14th International Symposium on Hepatitis C Virus and Related Viruses (2007) Abstract O-19
19. Barbarin V., Xing Z., Delos M., et al. Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am J Physiol Lung Cell Mol Physiol 288 (2005) 841-848
20. Nelson D.R., Tu Z., Soldevila-Pico C., et al. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 38 (2003) 859-868
21. Nunnari G., Nigro L., Palermo F., et al. Slower progression of HIV-1-infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 139 (2003) 26-30
22. Xiang J., Rydze R.A., Chang Q., et al. GB virus C infection and NS5A protein promote a Th1 cytokine profile in lymphocytes. General 107th Meeting of the American Society of Microbiology (2007)
23. Clerici M., and Shearer G. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 15 (1994) 575-581
24. Stapleton J.T., Williams C.F., and Xiang J. GB virus C: a beneficial infection?. J Clin Microbiol 42 (2004) 3915-3919
25. Maidana Giret M.T., Silva T.M., Levi J.E., et al. GBV-C infection is associated with less T cell activation in recently HIV-infected subjects and is independent of HIV-1 viral load. 4th IAS Conf HIV Pathog Treat (2007) Abstract No. MOAA105
26. Xiang J., McLinden J.H., Chang Q., et al. Identification of a 16 amino acid fragment within GBV-C NS5A protein that is required for HIV inhibition and downregulation of CD4 and CXCR4 in primary and transformed CD4+ T cells. 4th IAS Conf HIV Pathog Treat (2007) Abstract No. TUPDA05
27. Brau N., Salvatore M., Rios-Bedoya C.F., et al. Slower fibrosis progression of hepatitis C virus-related chronic liver disease in human immunodeficiency-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 44 (2006) 47-55
28. Margolis L. Cytokines-strategic weapons in germ warfare?. Nat Biotechnol 21 (2003) 15-16